BIOREGENX, INC. (BRGX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1M 2M 3M Q2 '24: 2.8M Q3 '24: 2.6M Q4 '24: 2.3M Q1 '25: 2.3M Q2 '25: 2M Q3 '25: 1.9M Q4 '25: 1.9M Q1 '26: 1.8M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Gross Profit TTM

0 700K 1.4M 2.1M Q2 '24: 1.8M Q3 '24: 1.7M Q4 '24: 1.7M Q1 '25: 1.7M Q2 '25: 1.6M Q3 '25: 1.5M Q4 '25: 1.5M Q1 '26: 1.4M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Operating Income TTM

-24M -16M -8M 0 8M 16M 24M Q2 '24: -6.8M Q3 '24: -4.7M Q4 '24: -22.8M Q1 '25: -19.9M Q2 '25: -18.9M Q3 '25: -18.6M Q4 '25: -1.2M Q1 '26: -1.1M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Net Income TTM

-24M -16M -8M 0 8M 16M 24M Q2 '24: -7M Q3 '24: -4.9M Q4 '24: -23.1M Q1 '25: -20.2M Q2 '25: -19.2M Q3 '25: -18.9M Q4 '25: -1.5M Q1 '26: -1.3M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Cost of Revenue TTM

0 350K 700K 1.1M Q2 '24: 952.9K Q3 '24: 843.9K Q4 '24: 681.7K Q1 '25: 625.4K Q2 '25: 454.8K Q3 '25: 421.7K Q4 '25: 350.9K Q1 '26: 319.6K Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Operating Cash Flow TTM

-900K -600K -300K 0 300K 600K 900K Q2 '24: -810.7K Q3 '24: -558.4K Q4 '24: -324.1K Q1 '25: -182.2K Q2 '25: -1.7K Q3 '25: -42K Q4 '25: 39K Q1 '26: 27.9K Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Free Cash Flow TTM

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q1 '24: -1.5M Q2 '24: -1M Q3 '24: -747.8K Q4 '24: -513.5K Q1 '25: -182.2K Q2 '25: -1.7K Q3 '25: -48K Q4 '25: 29.9K Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 350M 700M 1.1B Q3 '23: 621.9M Q1 '24: 767.6M Q2 '24: 956.5M Q3 '24: 956.5M Q1 '25: 957M Q2 '25: 959.2M Q3 '25: 960.9M Q1 '26: 969.2M Q3 '23 Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.02 -0.01 -0.01 0.00 0.01 0.01 0.02 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: -0.02 Q1 '25: -0.02 Q2 '25: -0.02 Q3 '25: -0.02 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.